Drug General Information
Drug ID	D0BT0Z
Former ID	DIB002076
Drug Name	PF-05241328
Indication	Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89]		Phase 1	[523119]
Company	Pfizer Inc
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Voltage-gated sodium channel subunit alpha Nav1.7	Target Info	Inhibitor	[532897]
Reactome	Interaction between L1 and Ankyrins
References
Ref 523119	ClinicalTrials.gov (NCT01165736) To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity. U.S. National Institutes of Health.
Ref 532897	Recent progress in sodium channel modulators for pain. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3690-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.